Evaluation of 9-cis retinoic acid for a new remedy of human retinoblastoma.

Biochemistry and molecular biology international

PubMedID: 9861453

Tsukamoto H, Kurokawa T, Hirata K, Ishibashi S, Mishima HK. Evaluation of 9-cis retinoic acid for a new remedy of human retinoblastoma. Biochem Mol Biol Int. 1998;46(5):987-91.
We investigated the effect of two isomers of retinoic acid (RA), all-trans RA and 9-cis RA, on the proliferation of Y79 human retinoblastoma cells. The two isomers inhibited the cell proliferation in a concentration-dependent manner. The IC50 for this inhibition by all-trans RA and 9-cis RA was 1. 50 and 0. 15 microM, respectively. The inhibitory effect of 9-cis RA on Y79 cell growth was observed within 24 hr, thereafter the cell number was gradually decreased. In contrast, no inhibition by all-trans RA of Y79 cell growth was observed within 24 hr, thereafter the cell number was slightly increased. In these cases, the cell viability at 4 days after the addition of 9-cis RA and all-trans RA was more than 90% and 95%, respectively. These results indicate that the two RA inhibit the proliferation of Y79 human retinoblastoma cells without inducing the cell death and that the effect of 9-cis RA on the inhibition of Y79 cell growth is much greater than that of all-trans RA.